NCT06797570View on ClinicalTrials.gov

The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

NANot yet recruitingINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

January 25, 2025

Primary Completion Date

January 6, 2027

Study Completion Date

January 6, 2027

Conditions

Attention Deficit DisorderAttention Deficit Disorder (ADD)Attention Deficit Disorder with HyperactivityADHDADDADHD-not Other SpecifiedADHD or ADHD TraitsADHD Predominantly Hyperactivity TypeADHD Predominantly Inattentive TypeADHD with Sleep Onset InsomniaADHD, ADDADHD, Predominantly Hyperactive - ImpulsiveADHD, Predominantly Inattentive TypeHyperactivityHyperactivity DisorderInattention

Interventions

OTHER

Communication Strategy for Side Effect Counseling in ADHD Treatment

One group receives negatively framed and extensive information about the most common adverse events of methylphenidate. A fixed script will be prepared for the treating paediatrician, and the same information will be provided in written form. The other group receives positively framed and concise information about the most common adverse events of methylphenidate. This information will also be provided in written form.

All Listed Sponsors

lead

St. Antonius Hospital

OTHER